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Background: Routine screening of scoliosis is a controversial subject and screening efforts vary greatly around the
world.
Methods: Consensus was sought among an international group of experts (seven spine surgeons and one clinical
epidemiologist) using a modified Delphi approach. The consensus achieved was based on careful analysis of a
recent critical review of the literature on scoliosis screening, performed using a conceptual framework of analysis
focusing on five main dimensions: technical, clinical, program, cost and treatment effectiveness.
Findings: A consensus was obtained in all five dimensions of analysis, resulting in 10 statements and
recommendations. In summary, there is scientific evidence to support the value of scoliosis screening with respect
to technical efficacy, clinical, program and treatment effectiveness, but there insufficient evidence to make a
statement with respect to cost effectiveness. Scoliosis screening should be aimed at identifying suspected cases of
scoliosis that will be referred for diagnostic evaluation and confirmed, or ruled out, with a clinically significant
scoliosis. The scoliometer is currently the best tool available for scoliosis screening and there is moderate evidence
to recommend referral with values between 5 degrees and 7 degrees. There is moderate evidence that scoliosis
screening allows for detection and referral of patients at an earlier stage of the clinical course, and there is low
evidence suggesting that scoliosis patients detected by screening are less likely to need surgery than those who
did not have screening. There is strong evidence to support treatment by bracing.
Interpretation: This information statement by an expert panel supports scoliosis screening in 4 of the 5 domains
studied, using a framework of analysis which includes all of the World Health Organisation criteria for a valid
screening procedure.Introduction
Adolescent idiopathic scoliosis (AIS) is a complex 3-D
deformation of the trunk, with a prevalence of 2-4%.
Among patients with AIS, 8% to 9% will be treated by
brace and 0.1% will need surgery using spinal instrumen-
tation and fusion. Routine screening of scoliosis is a con-
troversial subject and screening efforts vary greatly around
the world [1], with mandatory scoliosis school screening
programs (SSSP’s) in some areas, voluntary SSSP’s in
others, while some countries recommend against.* Correspondence: hubert.labelle@umontreal.ca
1Orthopedic Division, Sainte-Justine University Hospital, University of
Montreal, Montreal, Canada
Full list of author information is available at the end of the article
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stated.Currently, less than half of the states in the United States
have legislated school screening, while national SSSP’s in
Canada have been discontinued [2].
In 2008, the American Academy of Orthopaedic Sur-
geons (AAOS), the Scoliosis Research Society (SRS), the
Pediatric Orthopaedic Society of North America (POSNA),
and the American Academy of Pediatrics (AAP) issued an
information statement [3] on screening in AIS, indicating
that in 1996, the United States Preventive Services Task
Force (USPSTF) concluded that there was insufficient evi-
dence to make a recommendation for, or against, screening
[4]. However, in 2004, the USPSTF changed their position
and recommended against the routine screening of asymp-
tomatic adolescents for idiopathic scoliosis [5]. The AAOS,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Labelle et al. Scoliosis 2013, 8:17 Page 2 of 6
http://www.scoliosisjournal.com/content/8/1/17SRS, POSNA, and AAP expressed concerns that this
change in position by the USPSTF came in the absence
of any significant change in the available literature, in
the absence of any change in position statements by the
AAOS, SRS, POSNA, and AAP, and in the absence of
any significant input from specialists who commonly
care for children with scoliosis. The AAOS, SRS, POSNA,
and AAP did not support any formal recommendations
against scoliosis screening, given the available literature.
In 2010, the SRS Presidential line determined that it
would be worth exploring scoliosis screening from a
multi-national perspective by creating an International
Task Force. The goal of this article is to summarize the
activities of the Task Force over the past 2 years, leading
to the current consensus information statement on the
value of scoliosis screening based on the available scien-
tific literature.
Material & methods
Seven SRS members were nominated by the Presidential
line to join the Task Force (TF). Their selection was
based on their known expertise on scoliosis screening:
two members from USA, one from Canada, two from
Europe, and two from Asia. In addition, two clinical epi-
demiologists were added to provide methodological sup-
port and one research assistant to coordinate the team’s
effort. As one epidemiologist had clinical expertise on
the subject, he was invited to join the TF for input, so
that eight members voted on each issue discussed.
Two conference calls were first held to establish the
proper strategy to evaluate scoliosis screening. The first
decision was to take advantage of a recent systematicFigure 1 The conceptual framework used to analyze scoliosis screeni
relates to the validity and reliability of the tests; Clinical Effectiveness,
consequences of screening on patient management and the health s
patients of adherence to the screening programs; Cost-Effectiveness w
Treatment Effectiveness which concerns the benefits for patients of threview on the effectiveness of scoliosis screening [6], in
which four databases were searched: Medline, Embase,
CINAHL, EBM Reviews and Cochrane Central Registry
of Controlled Trials. All relevant studies between 1950
and mid 2010 were selected and independently reviewed
by two review authors (an epidemiologist and an ortho-
paedic surgeon). Key findings were summarized for each
article in narrative format: study design, sample size,
intervention (tools, personnel, setting, and population),
main outcomes, key message, original author’s main
conclusions, paper’s strengths and flaws, assessment of
risk of bias, critical appraisal of the conclusions and clin-
ical significance. Grading of the strength of evidence of
individual studies was done using the Downs & Black
28-item tool [7]. The conceptual framework of analysis
used in this systematic review was adopted by the Task
Force, as it was considered ideal to analyze scoliosis
screening, focusing on five main dimensions (Figure 1).
This model has been used in other screening programs
with success, and includes all of the World Health Or-
ganisation (WHO) criteria for a valid screening proced-
ure [8].
Since treatment effectiveness was not included in the
systematic review [6], and since a meta-analysis [9] pro-
viding a summary of the available evidence on brace
treatment up to 1993 was available, a Medline database
search of the French and English literature on brace
treatment in AIS was performed from 1993 to 2012, to
identify publications with level I, II or III evidence [10].
We therefore excluded all level IV (case series with no
control group or with an historical control group) and
all level V evidence (expert opinion). The search strategyng, focusing on five main dimensions: Technical Efficacy, which
which describes the importance of the health problem and the
ystem; Program Effectiveness which refers to the benefits for the
here these benefits are balanced against costs for society and
e available treatment modalities.
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systematic review which analyzed 2 level I and II studies,
one RCT and one prospective and controlled cohort.
Due to the wide geographical dispersion of the TF
members, the second decision was to use an interactive
website, Wikispaces, as the main tool to conduct the
work. A secured website was thus set-up, to which only
members were granted access. Instructions on how to
navigate through the site were provided. In each page,
members were able to browse the available information,
download and upload files, and post comments directly
on the page through a simple editing feature.
The online collaborative work began by answering two
preliminary questions, the first on the goal for SSSP’s
and the second on the analytical framework for screen-
ing program effectiveness (Figure 1). Each of the themes
was sequentially opened for study by all members for a
period of four to six weeks. The following information
was extracted from the systematic review [6], and was
made available for each on the website: a summary of
evidence tables in PowerPoint format, each article stud-
ied in PDF format and the detailed critical evaluation of
each article including the Downs & Black 28-item score.
For each theme, members were invited to answer a
series of statements derived from the critical review of
the literature, with an agreement scale (Strongly agree,
agree, disagree, strongly disagree), and designed to guide
members through the literature review and make their
own expert opinion based on the literature review. Each
member was asked to individually respond to each state-
ment, and return his answers confidentially to the website
manager by e-mail. For each section, once all responses
were returned and compiled, the results were presented
on the website. A period of four weeks was then allowed
in each section for members to freely discuss the results
and expand on the areas of disagreement. Following this
discussion, a wrap-up on the areas of consensus and dis-
agreement was done by the lead author to conclude each
website section. In addition, four face-to-face meetings of
the TF were held in 2011 and 2012, allowing members to
get training on use of the website, freely discuss areas of
controversy revealed on the website and prepare the cur-
rent consensus information statement.
Results
Additional file 1: Table S1 is a summary of each set of
statements for each of the five dimensions studied, with
agreement results in each dimension. For the prelimin-
ary questions, all agreed that Scoliosis screening should
be aimed at identifying suspected cases of scoliosis that
will be referred for diagnostic evaluation and confirmed,
or ruled out, with a clinically significant scoliosis (>10°
Cobb angle [12]). Participants also agreed that conclu-
sions on screening programs effectiveness should beprovided by carefully examining the available literature
according to the conceptual framework. For technical effi-
cacy, 42 articles were reviewed (Additional file 2, A1-A42)
and five questions asked. For clinical effectiveness, 58
articles were reviewed (Additional file 2, A43-A98) and
12 questions asked. This dimension is defined as the extent
to which an intervention does what it is aimed to do, in the
clinical setting [13]. For program effectiveness, 11 compara-
tive studies between participants and non participants to
screening programs were reviewed (Additional file 2,
A99-A109). Seven questions were asked for two separate
outcomes. In outcome A, the characteristics of the patients
at time of detection/diagnostic (in terms of age and Cobb
angle) were compared in screened and unscreened samples
of participants to determine if the goal of “early detection”
is achieved by these screening programs. In outcome B, the
reduction in the number of required surgeries was assessed,
which is the “ultimate goal” of screening for scoliosis [14].
For cost effectiveness, only 8 articles were available for re-
view (Additional file 2, A110-A117) and seven questions
were asked. Finally, for treatment effectiveness, our literature
search revealed 24 articles (Additional file 2, A118-A141)
on brace treatment in AIS with level I, II or III evidence
[10], leading to 7 questions.
Discussion
This critical analysis of the current literature revealed
many areas of agreement in all five dimensions which
will be further discussed.
Technical efficacy
Members agreed on the tools/techniques to be included
in the review and on the scoliometer as the best tool
(used alone with an Adams Forward bending test) in
terms of reliability and validity to measure trunkal asym-
metry (as proxy for spinal deformities). There is evidence
that scoliometer measures in the sitting position may be
useful, especially in patients presenting with important leg
length discrepancy. Members agreed on the relevant reli-
ability and validity values to evaluate the tools and tech-
niques of trunkal asymmetry measures (as a proxy for
spinal deformities). Work by Lee et al [15], (which is the
first study providing graphs of sensitivity and PPV accord-
ing to the threshold for positive cases) does not invalidate
the general recommendation about the use of the scoli-
ometer. It was noted that there is controversial evidence
that using Moiré Topography in combination with the
scoliometer may improve the sensitivity of the screening
protocol. TF members agreed that the recommended
threshold for the use of the scoliometer should be be-
tween 5° and 7° when used alone. The issue of the recom-
mended age for screening needs further clarification. The
literature is difficult to interpret but members agreed that
screening should be conducted two years before onset of
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moderate quality evidence to support measurement esti-
mates. Threshold determination for positive cases resulted
in an interval of values and the lack of prospective studies
was noted.
Clinical effectiveness
Members agreed on the definition of Clinical Effective-
ness, with the limitation that SSSP’s discover children
with trunk asymmetry, of which a portion will have
scoliosis. This discordance between spinal and surface
asymmetry/deformity in younger children leads to over-
referrals from SSSP’s and is the main cause of the on-
going controversy over its application. Therefore, future
studies of screening programs should try to determine
how many children with trunk asymmetry have scoliosis.
There was also agreement on the retained measures
(prevalence, referral rate, positive predictive value) for
this dimension, but one member thought that Sensitivity
should be added as another measures for clinical ef-
fectiveness. For question 3, there was consensus on the
definition for prevalence of scoliosis, but one member
disagreed since usually no treatment is offered for curves
<25°, and one member thought that the percentage of
curves >10° among those screened may over-estimate
the true prevalence. On question four, a majority of
members disagreed with the proposed definition of re-
ferral rates in orthopedics/specialized clinic, since pa-
tients who are referred and those who are actually seen
represent two distinctly separate situations. As the direct
output of screening programs, referral rate should be de-
fined as the percentage of screened individuals with a
positive test. For question 5 there was consensus on the
proposed definition for positive predictive value, but one
member questioned whether this value should be calcu-
lated for diagnosed cases of scoliosis > 10°, or for cases that
need clinical follow-up or treatment (for example, >20°).
To ease comparison, there was consensus that there are
advantages to rely on the standard definition of scoliosis.
There was consensus that Clinical Effectiveness is only
one of the dimensions of Effectiveness and that any deci-
sion on the global value of screening programs should
be taken by careful examination of all five dimensions.
For question seven, looking at the strongest evidence on
the studies providing estimates of clinical effectiveness
measures, members supported that the large retrospect-
ive follow-up study from Luk et al [16]. constitutes very
strong evidence that should lead decisions related to
clinical effectiveness of screening. Fong et al’s very rigor-
ous meta-analysis [17] provides estimates from 36 lower
quality studies and illustrates the heterogeneity of the
available studies. Age, gender, screening tests used, study
size, publication date, screening setting and even latitude
may be factors to investigate. Nevertheless, in thesestudies [16,17] as well as in 23/36 studies included in
Fong’s meta-analysis, the authors considered these as
«adequate values» and concluded on the Clinical Effect-
iveness of SSSP’s.
According to WHO’s [8] criteria, the condition should
be an important health problem, both in terms of mor-
bidity and disease frequency. Therefore, prevalence is
one important aspect of the decision. In addition, facil-
ities for diagnosis and treatment should be available, or
by extension, the volume and characteristics of patients
referred in orthopaedics for evaluation and diagnosis
should be considered as “appropriate” or manageable by
the health care system in order to provide adequate care.
As for question 11, there was consensus that scoliosis is a
condition amenable to screening, but members recognize
that this is an expert opinion from spine caregivers is
based on low to moderate evidence and that perspectives
could be different if respondents were independent non-
spine caregivers critically analyzing the same evidence.
Program effectiveness
Members noted the paucity of comparative studies in
the field of scoliosis screening. Based on the available lit-
erature, they agreed that screen detected scoliosis pa-
tients are younger and less severely affected at time of
detection and diagnosis than otherwise detected pa-
tients. However, even if the reported results are highly
consistent, members were not unanimous in grading the
proposed level of evidence as moderate, since individual
studies were low quality. TF members also agreed that
reduction in the number of surgeries is a major goal of
screening programs. There are no strong studies assessing
this outcome, because of poor design and heterogeneity in
results. All agreed that because this question could have
considerable impact for the patient and health system,
they should therefore put forth a conclusive statement on
the issue. TF members did not unanimously agree on the
proposed statement of the likelihood of an association be-
tween screening programs and reduction in surgery rate,
thus a consensus on the following reformulated recom-
mendation: there is some evidence, although low and
questionable that screen detected scoliosis patients are
less likely to be recommended for surgery than otherwise
detected patients.
Cost effectiveness
Members recognized that few studies focused on cost
analysis as their main objectives. Available studies need
to be analyzed carefully since the reported “total costs”
are based on different perspectives, making direct compari-
son of results difficult: program costs, program+ diagnostic
costs, program + diagnostic + follow-up costs, program +
diagnostic + follow-up + treatment costs. To ease compari-
son, members were provided with cost-charts adjusted for
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only at program costs, i.e. direct costs of the screening
intervention, costs ranged from 50 cents to $12/per
screened for FBT only or the scoliometer, $20 for the
protocol including Moiré topography. In absolute terms,
these costs were considered reasonably low. However,
costs increase substantially when considered for each
child brought to treatment. These numbers ought to be
analyzed in correspondence with measures of effective-
ness, i.e. with an evaluation of decreased overall expense
because of avoided surgeries and major interventions.
There were limited data exploring this question, with two
studies reviewed on cost-effectiveness, which actually
support cost-effectiveness of screening, but based on
disputable assumptions on bracing effectiveness. Mem-
bers supported further investigation by comparing two
comparable settings, one with screening programs and
one without (comparable cohorts from comparable health
and economic systems) or by comparing those screened
with those who had defaulted screening or who had
sought alternative non-operative treatment, in the same
health service area. The SRS could be a scientific and
operation leader in such an endeavor.
Treatment effectiveness
Finally, with respect to the controversial theme of brace
treatment efficacy (Additional file 2, A118-A141), the
Task Force consensus indicates that based on level II
and III evidence, there is scientific literature supporting
the short and long term efficacy of full-time brace wear
to prevent progression of AIS. With the recently pub-
lished results of the BrAIST multicenter NIH trial [19],
there is now level I evidence to support the efficacy of
brace treatment in AIS.
Conclusions
After a critical review of the available evidence, the SRS
International Task Force on Scoliosis screening, supported
by the SRS Board of Directors, makes the following state-
ments and recommendations regarding scoliosis screening:
1- Scoliosis screening is recommended as valuable in
the following domains: technical efficacy, clinical,
program and treatment effectiveness. The existing
literature does not provide sufficient evidence to
make a statement with respect to cost effectiveness.
2- Scoliosis screening should be aimed at identifying
suspected cases of scoliosis (labeled as “positive
cases” according to clearly defined criteria) that will
be referred for diagnostic evaluation and confirmed,
or ruled out, with a clinically significant scoliosis
(>10 degrees of Cobb angle). Females should be
screened twice, at age 10 and 12, and boys once, at
age 13 or 14 [3].3- The scoliometer is currently the best tool available
for scoliosis screening.
4- There is moderate evidence to recommend referral
with scoliometer values between 5° and 7°, or
greater. The addition of Moire topography may
improve sensitivity.
5- There is moderate evidence that the use of scoliosis
screening allows for detection and referral of
patients with AIS at an earlier stage of the clinical
course, in terms of younger age and/or lower Cobb
angle.
6- There is evidence that scoliosis patients detected by
screening are less likely to need surgery than those
patients who did not have screening.
7- Prevalence, Referral rates and Positive Predictive
Value of current screening tools in screened children
reach adequate values (expert opinion), so as to
consider scoliosis a condition suitable for screening.
8- There is strong evidence to support the value of
bracing for the treatment of AIS.
9- Continued work to determine minimum standards
and targets (in terms of referral rates and Positive
Predictive Value) is needed for screening programs.
10- Further investigation on cost-effectiveness of
screening programs should be obtained by studying
comparable settings: one with scoliosis screening,
and one without.
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